Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
With manufacturing footprints on five continents and a research pipeline spanning cutting-edge insecticides to plant biologicals, FMC Corporation produces disclosures packed with technical detail. For investors, locating environmental liabilities, regional crop-protection sales, or patent-expiration risks inside a 300-page filing can be daunting. FMC SEC filings explained simply means you can focus on decisions instead of decoding legal language.
Stock Titan’s AI reads every new document the moment it hits EDGAR, delivering concise highlights, plain-English definitions, and cross-links to prior periods. Whether you need the FMC quarterly earnings report 10-Q filing for margin trends, the FMC annual report 10-K simplified to spot R&D spend, or FMC 8-K material events explained after a sudden divestiture, the insights arrive in seconds. Real-time alerts surface FMC Form 4 insider transactions real-time, while side-by-side charts let you compare segments without scrolling through footnotes.
Typical questions—“What do FMC insider trading Form 4 transactions signal before planting season?” or “How does the proxy statement executive compensation align with long-term TSR?”—are answered inside interactive dashboards. You’ll also find:
- FMC executive stock transactions Form 4 with historical context
- FMC earnings report filing analysis that tracks active ingredient pricing
- Understanding FMC SEC documents with AI for quicker due diligence
- FMC proxy statement executive compensation microsummaries
From commodity exposure breakouts to patent pipeline timelines, every disclosure is paired with expert commentary, AI-powered summaries, and real-time updates. Make faster, better-informed decisions—minus the document overload.
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported two dispositions of common stock on 09/29/2025. She sold 3,790 shares at $34.00 and 5,177 shares at $33.64, reducing her direct beneficial ownership to 27,867 shares after the transactions. The filing notes the 3,790-share sale executed automatically under a Rule 10b5-1 trading plan adopted May 16, 2025. The Form 4 was signed by an attorney-in-fact on 09/30/2025.
Form 144 notice for FMC (FMC) reports a proposed sale of 3,790 common shares through Fidelity Brokerage Services with an aggregate market value of $128,860, with an approximate sale date of 09/29/2025. The shares were acquired on 09/27/2025 by restricted stock vesting from the issuer and the payment type is listed as compensation. The filing also discloses a prior sale by Jacqueline D. Scanlan of 1,510 shares on 08/18/2025 for gross proceeds of $56,609.90. The notice includes the mandatory representation that the seller does not possess undisclosed material adverse information about the issuer.
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported a sale of 1,510 shares of FMC common stock on 08/18/2025 at a price of $37.49 per share, reducing her beneficial ownership to 36,834 shares. The filing indicates the transaction was made pursuant to a Rule 10b5-1 plan. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Form 144 notice for FMC Corporation (FMC) reports a proposed sale of 1,510 common shares held in a brokerage account at Fidelity with an aggregate market value of $56,609.90. The shares were acquired on 09/27/2024 through restricted stock vesting as compensation, and the filer indicates an approximate sale date of 08/18/2025 on the NYSE. The filing shows 124,911,586 shares outstanding for context. No securities were reported sold by the filer in the past three months. The notice includes the standard representation that the seller has no undisclosed material adverse information.
FMC Corp. (FMC) Form 4: Director Carol Anthony Davidson reported the issuance of 113 common shares on 17 Jul 2025. The shares were granted at $0 cost as dividend-equivalent rights tied to previously vested restricted stock units. Following the transaction, Davidson’s direct holding rose to 13,085 shares. No derivative securities were exercised or disposed.
The filing reflects a routine, non-cash increase in insider ownership, signalling continued equity alignment but provides no indication of open-market buying or new strategic information. The size of the grant is immaterial relative to FMC’s average daily volume and market capitalization, so market impact is expected to be negligible.
On 21 Jul 2025 FMC Corporation (FMC) filed a Form 4 for director C. Scott Greer covering a 17 Jul 2025 transaction. Greer was credited with 388 common shares via dividend-equivalent rights tied to previously vested restricted stock units; no cash was paid (reported price $0). His direct beneficial ownership rose to 73,809 shares.
No common-stock sales, option exercises or new derivatives were disclosed, and board roles remain unchanged. The automatic share issuance represents less than 0.0003 % of FMC’s ~128 million shares outstanding, making the event routine and immaterial to valuation or governance considerations.
FAQ
What is the current stock price of Fmc (FMC)?
What is the market cap of Fmc (FMC)?
